| Impact of Multigrain Chapatti Consumption on Glycemic and Lipid Profiles in Type 2 Diabetes Patients |
| Paper ID : 1308-IGA |
| Authors |
|
Nauman Rasool * College of Food Science and Engineering, Yangzhou University, Hanjiang District, Yangzhou, Jiangsu, 225127, China |
| Abstract |
| This study assessed the effects of multigrain chapattis on metabolic health in 10 type 2 diabetes mellitus (T2DM) patients using a three-month randomized crossover design. Participants consumed three formulations MSC1 (50% wheat, 50% barley), MSC2 (50% wheat, 50% millet), and MSC3 (50% wheat, 10% each of barley, millet, chickpea, sorghum, maize) for three weeks each, with a one-week washout period between interventions. Fasting plasma glucose, lipid profiles, and renal function were measured before and after each intervention. Multigrain chapatti consumption significantly reduced fasting plasma glucose (from 165.47±30.97 to 140.15±24.96 mg/dl, p<0.05) and improved lipid profiles, including cholesterol (208.4±29.69 to 202.3±29.17 mg/dl, p<0.05) and LDL (131.8±24.07 to 118.1±23.73 mg/dl, p<0.05), with no significant differences among formulations (p=0.32). Renal function markers (urea, creatinine) remained within normal limits (p>0.05), indicating safety. These findings suggest that multigrain chapattis are a viable dietary intervention for improving glycemic control and lipid profiles in T2DM patients, supporting their potential as a sustainable nutritional strategy. Larger studies are needed to validate these results and explore underlying mechanisms. |
| Keywords |
| Type 2 Diabetes Mellitus (T2DM); Insulin; Dietary Fiber; Multigrain chapatti; Glycemic Control; Nutritional Intervention; Whole Grains. |
| Status: Accepted |
